TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Agreement that exercise is the best management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Extension of life
Endpoint domain: Mortality/survival
Primary endpoint: Size of radiolucent lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms (tenderness to percussion and/or pain on palpation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Th1-type and Th2-type cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acne symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in binge eating severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in mental health‐related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ORi values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EtO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of first aid intentions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in providing first aid
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual analogue scale (VAS) for pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SGRQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in percent of predicted FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean change in inspiratory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Need for initiation of additional BP-lowering agents
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Kidney failure, doubling of serum creatinine, or death caused by kidney or cardiovascular disease
Endpoint domain: Mortality/survival
Primary endpoint: Hair preservation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mature oocyte yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy against A. americanum nymphs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy against R. sanguineus (s.l.) nymphs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement Phenotypes
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total Sugar Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: zBMI Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-reported motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patient-centeredness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PFME knowledge improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PFME attitude improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: immediate posttest scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative consumption of sufentanil within 12 h postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of postoperative recovery scores at 48 h postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevention of new HIV infections
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in health costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: average numerical rating scale pain score over 72 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feelings of pleasure/displeasure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived effort (sRPE)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Postprandial plasma butyric acid incremental area under the curve (IAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oral glucose insulin sensitivity (OGIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of pre-diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of metabolic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak IGF‐I concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PINP AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Metastasis-free survival (MFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma HIV-1 RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cytokine responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: lymphocyte activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: median duration with Spo2 of less than 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Heart rate increase from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in BIT-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in visual acuity (logMAR) between at-home tests and in-office measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of seroma collections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean CNR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: women's experience of physical and/or sexual IPV
Endpoint domain: Adverse events/effects
Primary endpoint: men's perpetration of male-to-female physical and/or sexual IPV
Endpoint domain: Adverse events/effects
Primary endpoint: Development of Diabetic Retinopathy (DR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Average HbA1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Rankin scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: micturition frequency normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normalization of urgency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normalization of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global impression of change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and disability reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful lung re-expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of psychiatric disorders
Endpoint domain: Mortality/survival
Primary endpoint: average percentage of questions answered correctly
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Declines in adolescent-report inattentive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Declines in caregiver-report hyperactive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance in treatment sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total teachers' stress score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in auditory hallucination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrement in re hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in drug compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: syrinx resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24EE during fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fecal ammonia concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood total B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diagnostic accuracy of funduscopic examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total area of retinal hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: development of disc neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: presence of papillary swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Acceptance of integrated smoking cessation treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional performance in the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour postoperative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: compensation during aerobic exercise training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical Site Infection (SSI) identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Efficacy of lornoxicam compared to reference drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile analysis
Endpoint domain: Adverse events/effects
Primary endpoint: diabetes-specific experiences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COVID-19-specific distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Symptoms of goiter, anxiety, and depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FTBAs level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SARS‐CoV‐2 IgG antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: craniocervical flexion test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extubation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fundamental Movement Skill Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation induction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-1β levels in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: progression-free survival at 6 months (PFS-6)
Endpoint domain: Mortality/survival
Primary endpoint: KDT speed improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of making a quit attempt
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life for children with spinal muscular atrophy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: overall antibiotic prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total broad-spectrum prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS itch score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enhanced physical activity confidence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FAST scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAKT scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral blood Tregs increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Variation in incisor torque (degrees)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisor retraction (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (QoL) perception
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain perception
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Fall risk awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: WHODAS-score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: dual-task cost to step length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10y overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: 5y progression to multiple myeloma free survival (PMFS)
Endpoint domain: Mortality/survival
Primary endpoint: Total score of eye fatigue symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visuognosis persistence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear secretion (Schirmer test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic BP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diastolic BP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreases in suicidal ideation and behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGIC and PROMIS scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive Predictive Values (PPVs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADAMTS13 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Midwife time reduction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Obstetrician time reduction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Allograft failure from any cause including death
Endpoint domain: Mortality/survival
Primary endpoint: Allograft failure censored for patient death
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative thoracoscopic exploration time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: serum lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of condom-protected sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Current use of birth control other than condoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Intentions to use birth control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Nocturnal glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of Ventilator-Associated Pneumonia (VAP)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction with provider
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anticipatory guidance retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum depression screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of solid food early
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visibility of neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ΔE values for gastric neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: lateral decentration in x-direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of serious pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of COVID-19 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to TOF greater than 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSATS rating score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recovery PIPP scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival after recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Gains in QALYs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: metascore slopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-cardiovascular hospitalizations
Endpoint domain: Mortality/survival
Primary endpoint: Risk of developing abdominal obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Central obesity prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: necessity of GBR procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: pain experienced by patients
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: New vertebral fracture rates
Endpoint domain: Adverse events/effects
Primary endpoint: uptake of glaucoma screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: jaw functional limitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systemic exposure over 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum plasma concentration of erlotinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimal plasma concentration of erlotinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core Temperature (Trec)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sprint Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HOMA‐IR value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean HOMA‐β index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antibody signatures for CD and UC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the curve (AUC) for biomarker panels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Content validity of the 39-item checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Content validity of the 1-item OSATS GRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of scores from both instruments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of radiation exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Actigraphic activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rotator cuff strength gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: supraspinatus tendon thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Complete Renal Response (CRR) at one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: CAPS-IV total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD criteria met
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: depression symptom severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Value of in-person follow-up with primary care provider
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in MFPDI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: endorsements of language concerns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes